SAM #36C26227Q0072

VA Long Beach intends to sole-source Pylarify radiopharmaceutical injections

VA Long Beach Healthcare System plans to obtain Pylarify for prostate-cancer PET/CT imaging through an intended sole-source order. - Buyer: Department of Veterans Affairs, Long Beach Healthcare System, Network Contracting Office 22. - Planned procurement: Firm-fixed-price delivery order for Pylarify (piflufolastat F18) radiopharmaceutical injections. - Intended vendor/OEM: Progenics Pharmaceuticals, Inc.; the product is available under VA National Acquisition Center Federal Supply Schedule contract 36F79725D0093. - Purpose: Used with PET/CT scans to detect tumors expressing prostate-specific membrane antigen (PSMA), including tumors in the prostate, lymph nodes, bones, and other organs. - Quantity and delivery schedule: Not specified. - Notice status: This is a notice of intent to sole source, not a solicitation. Interested capable parties may submit information showing they can provide the same items and explaining how competition would benefit the Government.

Description

INTENT TO SOLE SOURCE This notice of intent to sole source is to make a sole award firm-fixed-price contract. The Department of Veterans Affairs Long Beach Healthcare System, located at 5901 East 7th Street, Long Beach, CA 90822 is issuing this notice of intent to inform industry contractors of the Government s intent to execute a sole source delivery order in accordance with Revolutionary FAR Overhaul (RFO) Part 8.401, GSAM/R 538.7104-3(b)(ii) Only one source available, and GSAM/R 538.7104-4 Items Peculiar to one manufacturer. The North American Industry Classification System (NAICS) for this requirement is 325412, Pharmaceutical Preparation Manufacturing with a size standard of 1,300 Employees. A Long Beach Healthcare System Nuclear Medicine department has a requirement for radiopharmaceuticals injections of Pylarify (piflufolastat F18). This is an advanced diagnostic imaging agent used with Positron Emission Tomography (PET)/Computed Tomography (CT) scans to find tumors in the prostate which identify the prostate-specific membrane antigen (PSMA), as well as in lymph nodes, bones, and other organs. The intended contractor is Progenics Pharmaceuticals, Inc located at 331 Treble Cove Road, N. Billerica, MA 01862. Requested Pylarify (piflufolastat F18) is available under the existing VA National Acquisition Center Contract (NAC) Federal Supply Schedule (FSS)# 36F79725D0093, effective from 04/01/2025 through 03/31/2030. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals. THIS IS NOT A SOLICITIATION. No award will be made as a result of any quotations received in response to this notice. The intent of this notice is for informational purposes only. A determination by the Government not to compete this action based on this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any responses to this notice must show clear and compelling evidence that the responding company can provide the same items, and that competition will be advantageous to the Government. All inquiries and correspondence must be addressed in writing via e-mail to Melissa Ramirez, Contracting Specialist, at Melissa.Ramirez8@va.gov with VA LB Pylarify Intent to Sole Source Response in the subject line. Telephone requests will not be honored. All interested parties who are responsible, certified, and capable may identify their interest and may submit a capabilities statement no later than November 3rd, 2026 10:00 AM Pacific Local Time. The interested parties bear full responsibility to ensure complete transmission and timely receipt.

View original listing